Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Galena Biopharma, Inc.

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Galena Biopharma, Inc.

[Business Wire] – Robbins Geller Rudman & Dowd LLP today announced that a class action has been commenced in the United States District Court for the District of Oregon on behalf of purchasers of Galena Biopharma, Inc. more

View todays social media effects on GALE

View the latest stocks trending across Twitter. Click to view dashboard

See who Galena is hiring next, click here to view

Share this post